维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

7篇 您的检索式：作者名="CONTI Monica"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection显示文摘	Marcella Visentini Serena Ludovisi Antonio Petrarca Federica Pulvirenti Marco Zaramella Monica Monti Valentina Conti Jessica Ranieri Stefania Colantuono Elisa Fognani Alessia Piluso Carmine Tinelli Anna Linda Zignego Mario U. Mondelli Massimo Fiorilli Mil	2011	Autoimmunity Reviews2011，，11：	1
	2	Quantitation of glycated hemoglobins in human adult blood by capillary isoelectric focusing 显示文摘	Monica Conti Cecilia Gelf Adriana Bianchi Bosisio	1996	Electrophoresis1996，17，10：	1
	3	Weakly dissipative semilinear equation of viscoelasticity显示文摘	CONTI Monica PATA Vittorino	2005	Comm on Pure and Appl Anal2005，4，：	1
	4	Noninvasive posititve pressure ventilation vs conventional oxygen supplementation in hypoxernic patients undergoing diagnostic bronchoscopy 显示文摘	Antonelli M Giorgio Conti Monica Rocco	2002	Chest2002，121，：	1
	5	Influence of Glutaraldehyde on Drug Release and Mucoadhesive Properties of Chitosan Microspheres 显示文摘	Ida Genta Monica Costantini Annalia Asti Bice Conti Luisa Montanari	1998	Carbohydrate polymers1998，36，2：	1
	6	Influce of glutaraldehyde on drug release and mucoadhesive properties of ehitosan microspheres 显示文摘	Ida Genta Monica Costantini Annalia Asti Bice Conti Luisa Montanari	1998	Carbohydrate polymers1998，，36：	1
	7	Optimization of the pharmacological therapy in patients with polyvascular disease: A multidisciplinary approach显示文摘The recent shift of the concept of cardiovascular disease as a chronic progressive condition,potentially involving multiple districts,has driven attention to the optimal management of patients with concomitant coronary and peripheral artery disease,representing a subset of patients with an increased risk of events and impaired survival.Recent pharmacological achievements in terms of antithrombotic therapy and lipid-lowering drugs allow multiple therapeutical combinations,thus requiring optimizing the treatment in a tailored fashion according to patients’risk profiles.Nevertheless,data dedicated to this specific subset of patients are still modest.We summarize currently available strategies and indications for the management of antithrombotic and lipid-lowering drugs in patients with the poly-vascular disease.	Rocco Gioscia Claudio Castagno Monica Verdoia Barbara Conti Enzo Forliti Andrea Rognoni	2023	World Journal of Cardiology2023，15，4：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费